Y. Bécouarn
Y. Bécouarn publishes mostly in Oncology, Surgery and Pulmonary and Respiratory Medicine, on topics such as Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology and Colorectal Cancer Surgical Treatments.
- World rank
- #922,601 of 7,710,434 ranked researchers
- Rank in France
- #43,933 of 324,115
- Works
- 130
- Citations
- 14k
- Citations per work
- 111.0
What does Y. Bécouarn research?
Y. Bécouarn's work is mostly in Medicine (82%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences10782.5%
- Medicine10782.5%
- Everything else1813.9%
- Life Sciences53.6%
- 1Oncology43% of their works
- 2Surgery16% of their works
- 3Pulmonary and Respiratory Medicine12% of their works
- 4Hepatology6% of their works
- 5Pathology and Forensic Medicine4% of their works
- 6Cancer Research4% of their works
Research topics
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Colorectal Cancer Surgical Treatments
- Gastric Cancer Management and Outcomes
- Hepatocellular Carcinoma Treatment and Prognosis
- Colorectal and Anal Carcinomas
- Pancreatic and Hepatic Oncology Research
- Genetic factors in colorectal cancer
Which keywords describe Y. Bécouarn's research?
The keywords of their largest research topics: Chemotherapy, Clinical Practice Guidelines, Cetuximab, KRAS Mutations, Quality of Life, Neoadjuvant Therapy, Adjuvant Chemotherapy and Molecular Characterization.
- Microsatellite Instability
- Surgical Complications
- Chemoradiation
- Liver Cancer
- Gastric Cancer
- Taxanes
- Preoperative Chemoradiotherapy
- Molecular Characterization
- Neoadjuvant Therapy
- KRAS Mutations
- Clinical Practice Guidelines
- Chemotherapy
- Cetuximab
- Quality of Life
- Adjuvant Chemotherapy
- Chemotherapy-Induced Peripheral Neuropathy
- Rectal Cancer
- Endoscopic Resection
- Hepatocellular Carcinoma
- Anal Cancer
- Pancreatic Cancer
- Hereditary Syndromes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Chemotherapy1114 topics
- Clinical Practice Guidelines643 topics
- Cetuximab621 topic
- KRAS Mutations621 topic
- Quality of Life412 topics
- Neoadjuvant Therapy382 topics
- Adjuvant Chemotherapy372 topics
- Molecular Characterization322 topics
- Chemotherapy-Induced Peripheral Neuropathy251 topic
- Preoperative Chemoradiotherapy251 topic
- Rectal Cancer251 topic
- Taxanes251 topic
- Endoscopic Resection201 topic
- Gastric Cancer201 topic
- Hepatocellular Carcinoma191 topic
- Liver Cancer191 topic
- Anal Cancer161 topic
- Chemoradiation161 topic
- Pancreatic Cancer131 topic
- Surgical Complications131 topic
- Hereditary Syndromes121 topic
- Microsatellite Instability121 topic
Where does Y. Bécouarn work?
Y. Bécouarn's main affiliation in the publication record is Institut Bergonié, France.
How many publications and citations does Y. Bécouarn have?
OpenAlex counts 130 works and 14,431 citations for Y. Bécouarn, an h-index of 32, ranking #922,601 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Y. Bécouarn. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.